EpiShuttles to the Democratic Republic of Congo in response to Ebola outbreak
Development of the EpiShuttle was initiated after experience that the medical team at the Oslo University Hospital had in treating an Ebola patient during the outbreak in 2014. In April this year, the first suspected cases of a new Ebola outbreak were reported in the Democratic Republic of Congo. As of May 24, the World Health Organisation (WHO) reports at least 54 cases, including 23 deaths.
EpiGuard are very proud to now be a part of the Norwegian Government’s contribution to help control the outbreak in Congo. Three EpiShuttles will be provided to the WHO to help ensure safe isolation and transportation of patients in the region. We will also provide training and a number of disposable kits to ensure safe usage in the field.
The first EpiShuttles are being sent this week and we have dedicating existing stock to support the situation in DRC. In parallel, we are working with our supply chain to reduce delivery time for new devices.
While we are working hard to respond quickly to this specific crisis, it is, of course, better to have the response ready and stock in place before a critical situation arises. EpiGuard are in contact with many organizations that are preparing and planning their response to potential future outbreaks of high consequence infectious diseases such as Ebola, MERS, SARS, Lassa fever, Marburg virus, and others.
If you would like to talk about how the EpiShuttle can be part of your response, please don’t hesitate to contact us!
Connect with us on social and don’t miss news like this!
Have any questions?
DISCLAIMER: The medical device information is provided for general informational and educational purposes only and is not a substitute for professional advice. Accordingly, before taking any actions based upon such information, we encourage you to consult with the appropriate professionals. The use or reliance of any information contained on the site is solely at your own risk. The EpiShuttle does not protect against all types of CBRN occurrences. Accordingly please consult with medical professionals before usage.